These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12830415)

  • 21. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
    Yamada N; Nagai H
    Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
    Apers L; Lynen L; Worodria W; Colebunders R
    Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies.
    Hesseling AC; Cotton MF; Jennings T; Whitelaw A; Johnson LF; Eley B; Roux P; Godfrey-Faussett P; Schaaf HS
    Clin Infect Dis; 2009 Jan; 48(1):108-14. PubMed ID: 19049436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current issues in global tuberculosis control.
    Frothingham R; Stout JE; Hamilton CD
    Int J Infect Dis; 2005 Nov; 9(6):297-311. PubMed ID: 16183319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
    Tappero JW; Bradford WZ; Agerton TB; Hopewell P; Reingold AL; Lockman S; Oyewo A; Talbot EA; Kenyon TA; Moeti TL; Moffat HJ; Peloquin CA
    Clin Infect Dis; 2005 Aug; 41(4):461-9. PubMed ID: 16028152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
    Swaminathan S; Padmapriyadarsini C; Sukumar B; Iliayas S; Kumar SR; Triveni C; Gomathy P; Thomas B; Mathew M; Narayanan PR
    Clin Infect Dis; 2008 Mar; 46(6):946-9. PubMed ID: 18279043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of anti-tuberculosis treatment and HIV serostatus.
    Lanternier F; Dalban C; Perez L; Bricaire F; Costagliola D; Caumes E
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1203-9. PubMed ID: 17958982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.
    Sonnenberg P; Glynn JR; Fielding K; Murray J; Godfrey-Faussett P; Shearer S
    J Infect Dis; 2005 Jan; 191(2):150-8. PubMed ID: 15609223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of HIV infected children with culture confirmed tuberculosis.
    Hesseling AC; Westra AE; Werschkull H; Donald PR; Beyers N; Hussey GD; El-Sadr W; Schaaf HS
    Arch Dis Child; 2005 Nov; 90(11):1171-4. PubMed ID: 15964862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions.
    Lawn SD; Bekker LG; Middelkoop K; Myer L; Wood R
    Clin Infect Dis; 2006 Apr; 42(7):1040-7. PubMed ID: 16511773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.
    Breen RA; Miller RF; Gorsuch T; Smith CJ; Ainsworth J; Ballinger J; Swaden L; Cropley I; Johnson MA; Lipman MC
    J Infect Dis; 2006 May; 193(10):1437-40. PubMed ID: 16619192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.
    Bonnet MM; Pinoges LL; Varaine FF; Oberhauser BB; O'Brien DD; Kebede YY; Hewison CC; Zachariah RR; Ferradini LL
    AIDS; 2006 Jun; 20(9):1275-9. PubMed ID: 16816556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lingual ulcer as the only sign of recurrent mycobacterial infection in an HIV/AIDS-infected patient.
    Ramírez-Amador V; Anaya-Saavedra G; González-Ramírez I; Mosqueda-Gómez JL; Esquivel-Pedraza L; Reyes-Gutiérrez E; Sierra-Madero J
    Med Oral Patol Oral Cir Bucal; 2005; 10(2):109-14. PubMed ID: 15735542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
    Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
    Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.